Phase 5: Maintenance dose (week 17 onward) Dose: 2.4 mg once weekly (maximum therapeutic dose for weight management) At the maximum 2.4 mg dose, even 2.5 mg/mL is getting close to syringe capacity at 96 units
Why Genetic Testing Matters for Supplement Strategy One-size-fits-all supplement advice often fails because individual genetic architecture shapes nutrient response
The exact mechanism by which semaglutide might cause taste alterations is not fully established, as there is no direct link confirmed in the FDA prescribing information
Life after Wegovy isnt just about the number on the scales
Binding increases insulin secretion which lowers glucose levels, reduces post-prandial glucagon secretion, promotes early satiety ( you feel full faster ), slows down gastric emptying ( you stay feeling full longer ), and helps reduce appetite & cravings
Patients taking semaglutide with insulin or sulfonylureas should be particularly vigilant about consistent dosing, as these combinations can increase hypoglycemia risk
